© 2022 MJH Life Sciences and Drug Topics. All rights reserved.
© 2022 MJH Life Sciences™ and Drug Topics. All rights reserved.
May 16, 2022
Real-world study conducted in Japan shows Dupixent (dupilumab) reduced the number of annual severe asthma exacerbations by 53%, there were also adverse events associated with high eosinophil levels in patients who had switched from a different biologic before starting Dupixent.
May 13, 2022
Xolair (omalizumab), Fasenra (benralizumab), Dupixent (dupilumab) and Nucala (mepolizumab) can now be self-administered.
May 09, 2022
Pharmacists are essential for managing complex CF regimens, monitoring their effectiveness, and improving adherence.
May 03, 2022
This year’s theme is focused on raising awareness about current gaps in care.
April 20, 2022
E-cigarettes may be helpful for smoking cessation.
March 19, 2022
Keeping OTC products near the pharmacy counter creates an opportunity for patient counseling and education.
March 04, 2022
Allergic asthma can be a complicated and confusing diagnosis.
February 02, 2022
Patients seeking OTC remedies for asthma should be counseled on the risks associated with OTC asthma products.
July 14, 2021
Tezepelumab is the first biologic medication to show a reduction in severe asthma symptoms.
July 09, 2021
Pharmacists can offer OTC recommendations for symptom relief.